BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Multani A, Ho DY. JC Polyomavirus Infection Potentiated by Biologics. Infect Dis Clin North Am 2020;34:359-88. [PMID: 32444013 DOI: 10.1016/j.idc.2020.02.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Hildreth J, Alcendor D. JC Polyomavirus and Transplantation: Implications for Virus Reactivation after Immunosuppression in Transplant Patients and the Occurrence of PML Disease. Transplantology 2021;2:37-48. [DOI: 10.3390/transplantology2010004] [Reference Citation Analysis]
2 Zheng HC, Xue H, Jin YZ, Jiang HM, Cui ZG. The Oncogenic Effects, Pathways, and Target Molecules of JC Polyoma Virus T Antigen in Cancer Cells. Front Oncol 2022;12:744886. [PMID: 35350574 DOI: 10.3389/fonc.2022.744886] [Reference Citation Analysis]
3 Melong Pianta Taleng CM, Lauper K, Gilbert B, Cunningham T, Guemara R, Brulhart L, Dan D, Courvoisier D, Finckh A. Incidence of COVID-19 in patients treated with infliximab compared with patients treated with rituximab. RMD Open 2021;7:e001711. [PMID: 34862310 DOI: 10.1136/rmdopen-2021-001711] [Reference Citation Analysis]
4 Cox D. How not to discover a drug - integrins. Expert Opin Drug Discov 2021;16:197-211. [PMID: 32921156 DOI: 10.1080/17460441.2020.1819234] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]